India's drug regulator inspected 90% of cough syrup makers, found lapses in some, official says

India's drug regulator inspected 90% of cough syrup makers, found lapses in some, official says

India's ‌drug regulator has inspected nearly 90% ‌of the country's cough syrup makers and found compliance lapses in some, its ⁠chief said on Monday, amid heightened scrutiny after India-made syrups were linked to the deaths of children in the country and abroad. The inspections follow the discovery of a brand of cough syrup contaminated with diethylene glycol that was linked to the deaths of 24 children in October last year. The product, named Coldrif, was made by Sresan Pharmaceutical, based ​in Tamil Nadu. "We took serious actions on serious non-compliances, and our belief is that the rot of cough syrup manufacturing will be removed," Drugs Controller General of India ‌Rajeev Raghuvanshi said at the IPA ⁠11th Global Pharmaceutical ​Quality Summit in Mumbai.